QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

NCT03197571 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Trial not initiated

Conditions

Urothelial Carcinoma

Interventions

BIOLOGICAL: avelumab
BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: 5Fluorouracil (5-FU)
DRUG: fulvestrant
DRUG: leucovorin
DRUG: nab-paclitaxel
DRUG: Lovaza
RADIATION: Stereotactic Body Radiation Therapy
BIOLOGICAL: ALT-803
BIOLOGICAL: ETBX-011
BIOLOGICAL: ETBX-021
BIOLOGICAL: ETBX-051
BIOLOGICAL: ETBX-061
BIOLOGICAL: GI-4000
BIOLOGICAL: GI-6207
BIOLOGICAL: GI-6301
BIOLOGICAL: haNK

Sponsor

ImmunityBio, Inc.